English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51950251    在线人数 :  813
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"jen chang ko"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 126-150 / 290 (共12页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-03-11T08:34:20Z Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan Lee M.-R.;Ho C.-M.;Lee C.-H.;Lee M.-C.;Chang L.-Y.;Yu K.-L.;Jen-Chang Ko;Wang J.-Y.;Wang J.-T.;Lee L.-N.; MENG-RUI LEE; Cheng-Maw Ho; Chih-Hsin Lee; Ming-Chia Lee; LIH-YU CHANG; KAI-LUN YU; JEN-CHANG KO; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
臺大學術典藏 2021-03-11T08:34:20Z Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏 2021-03-11T08:34:20Z Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏 2021-03-11T08:34:20Z Cementing an unwanted relationship Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏 2021-03-11T08:34:20Z Cementing an unwanted relationship Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏 2021-03-11T08:34:19Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:34:19Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:34:19Z Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏 2021-03-11T08:34:19Z Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏 2021-03-11T08:34:19Z Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏 2021-03-11T08:34:19Z Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏 2021-03-11T08:34:18Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:34:18Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:34:18Z Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:18Z Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:18Z Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:18Z Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:17Z Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏 2021-03-11T08:34:17Z Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏 2021-03-11T08:34:17Z Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏 2021-03-11T08:34:17Z Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏 2021-03-11T08:34:17Z Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:17Z Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:16Z Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏 2021-03-11T08:34:16Z Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.

显示项目 126-150 / 290 (共12页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目